Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20028004rdf:typepubmed:Citationlld:pubmed
pubmed-article:20028004lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C0011923lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C0031268lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C0006118lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C0060058lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C2347885lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C0072186lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:20028004lifeskim:mentionsumls-concept:C0599278lld:lifeskim
pubmed-article:20028004pubmed:issue2lld:pubmed
pubmed-article:20028004pubmed:dateCreated2010-1-21lld:pubmed
pubmed-article:20028004pubmed:abstractTextThe non-natural amino acids (R)- and (S)-2-amino-3-fluoro-2-methylpropanoic acid 5 and (R)- and (S)-3-fluoro-2-methyl-2-N-(methylamino)propanoic acid 8 were synthesized in shorter reaction sequences than in the original report starting from enantiomerically pure (S)- and (R)-alpha-methyl-serine, respectively. The reaction sequence provided the cyclic sulfamidate precursors for radiosynthesis of (R)- and (S)-[(18)F]5 and (R)- and (S)-[(18)F]8 in fewer steps than in the original report. (R)- and (S)-[(18)F]5 and(R)- and (S)-[(18)F]8 were synthesized by no-carrier-added nucleophilic [(18)F]fluorination in 52-66% decay-corrected yields with radiochemical purity over 99%. The cell assays showed that all four compounds were substrates for amino acid transport and enter 9L rat gliosarcoma cells in vitro at least in part by system A amino acid transport. The biodistribution studies demonstrated that in vivo tumor to normal brain ratios for all compounds were high with ratios of 20:1 to115:1 in rats with intracranial 9L tumors. The (R)-enantiomers of [(18)F]5 and [(18)F]8 demonstrated higher tumor uptake in vivo compared to the (S)-enantiomers.lld:pubmed
pubmed-article:20028004pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:languageenglld:pubmed
pubmed-article:20028004pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:citationSubsetIMlld:pubmed
pubmed-article:20028004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20028004pubmed:statusMEDLINElld:pubmed
pubmed-article:20028004pubmed:monthJanlld:pubmed
pubmed-article:20028004pubmed:issn1520-4804lld:pubmed
pubmed-article:20028004pubmed:authorpubmed-author:OlsonJeffrey...lld:pubmed
pubmed-article:20028004pubmed:authorpubmed-author:YuWeipingWlld:pubmed
pubmed-article:20028004pubmed:authorpubmed-author:GoodmanMark...lld:pubmed
pubmed-article:20028004pubmed:authorpubmed-author:McConathyJona...lld:pubmed
pubmed-article:20028004pubmed:authorpubmed-author:MalveauxEugen...lld:pubmed
pubmed-article:20028004pubmed:authorpubmed-author:CampVernon...lld:pubmed
pubmed-article:20028004pubmed:authorpubmed-author:ZhangZhaobinZlld:pubmed
pubmed-article:20028004pubmed:authorpubmed-author:WilliamsLarry...lld:pubmed
pubmed-article:20028004pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20028004pubmed:day28lld:pubmed
pubmed-article:20028004pubmed:volume53lld:pubmed
pubmed-article:20028004pubmed:ownerNLMlld:pubmed
pubmed-article:20028004pubmed:authorsCompleteYlld:pubmed
pubmed-article:20028004pubmed:pagination876-86lld:pubmed
pubmed-article:20028004pubmed:dateRevised2011-7-20lld:pubmed
pubmed-article:20028004pubmed:meshHeadingpubmed-meshheading:20028004...lld:pubmed
pubmed-article:20028004pubmed:meshHeadingpubmed-meshheading:20028004...lld:pubmed
pubmed-article:20028004pubmed:meshHeadingpubmed-meshheading:20028004...lld:pubmed
pubmed-article:20028004pubmed:meshHeadingpubmed-meshheading:20028004...lld:pubmed
pubmed-article:20028004pubmed:meshHeadingpubmed-meshheading:20028004...lld:pubmed
pubmed-article:20028004pubmed:meshHeadingpubmed-meshheading:20028004...lld:pubmed
pubmed-article:20028004pubmed:meshHeadingpubmed-meshheading:20028004...lld:pubmed
pubmed-article:20028004pubmed:meshHeadingpubmed-meshheading:20028004...lld:pubmed
pubmed-article:20028004pubmed:meshHeadingpubmed-meshheading:20028004...lld:pubmed
pubmed-article:20028004pubmed:meshHeadingpubmed-meshheading:20028004...lld:pubmed
pubmed-article:20028004pubmed:meshHeadingpubmed-meshheading:20028004...lld:pubmed
pubmed-article:20028004pubmed:year2010lld:pubmed
pubmed-article:20028004pubmed:articleTitleSynthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging brain tumors.lld:pubmed
pubmed-article:20028004pubmed:affiliationDepartment of Radiology, School of Medicine, Emory University, 1364 Clifton Road NE, Atlanta, Georgia 30322, USA.lld:pubmed
pubmed-article:20028004pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20028004pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:20028004lld:chembl